Keywords: cytogen, 4th-qtr, sales, up, biopharmaceutical, firm, reported
Cytogen's 4th-qtr sales up 28% to $3.4 m
Article | 15 March 2004
US biopharmaceutical firm Cytogen reported record product revenues of $3.4 million for the fourth quarter of 2003, rising 28% from the like, year-earlier ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
